First eye patient receives synthetic cornea

Date:
Mor Dickman

For the first time in Utrecht, a synthetic cornea was transplanted into a patient with a complex eye condition. The artificial cornea is an interesting alternative due to the donor shortage, and is a prelude to regenerative corneal transplants with cultured cells.

‘With my research, I am pushing for these types of implants to become regenerative. That means they will also contain cells and thus actually repair the cornea. The current synthetic implant can be a prelude to that, because this kind of material can also be the carrier of those cells,’ said UMC Utrecht professor of ophthalmology Mor Dickman, who recently performed the transplant with the synthetic cornea.

Major shortage of donor corneas

About 2,000 cornea transplants take place in the Netherlands every year, making it the most frequently performed transplant. Many of the recipients of such a transplant are elderly people, but younger patients and children also sometimes receive a cornea. Unfortunately, there is a huge shortage of donor corneas: there is about 1 donor for every 70 patients.

Corneal transplantation at UMC Utrecht.

An alternative graft

Because of the donor shortage, there is a great drive to find alternatives. It is the personal motivation of Professor of Ophthalmology Mor Dickman, who is now placing a synthetic corneal transplant in Utrecht for the first time. ‘This implant is made of a kind of contact lens material,’ he explains. ‘In this case, it replaces the inner part of the cornea.’

In the Netherlands, this technique is particularly interesting for patients with a high risk of rejection or graft failure. Mor: ‘These include patients with multiple previous transplants, a history of rejection, or after glaucoma surgery where small tubes are placed in the eye. There are also patients who do not want to receive donor tissue for cultural or religious reasons, and then this can be an alternative.’

Towards regenerative treatment

The synthetic implant was developed by a company, Eye-Yon. ‘Currently, we only apply this technique to the most complex cases,’ says Mor. ‘With further refinement and development, this technique could be a solution for a wider patient group in the future.’ An additional advantage is that a synthetic implant presents much less logistical challenges than a donated cornea.

In the further future, Mor sees other developments ahead. ‘With my research, I am pushing for these kinds of implants to become regenerative. That means they will also contain cells and thus actually repair the cornea. The current synthetic implant can be a prelude to that, because this kind of material can also be the carrier of those cells.’

Olympic champion Maarten van der Weijden swims one last time, now for the Máxima

Maarten van der Weijden is putting on his swimming suit one last time to raise money for cancer research. From 17 to 22 August, he will swim an incredible 270 kilometers through 22 cities, with the Princess Máxima Center as his final destination. With this special challenge, he is raising money for pioneering research into the immediate and long-term effects of childhood cancer.

New exit for construction traffic at the Utrecht Science Park

Various construction works are taking place in the north-west cluster of Utrecht Science Park. This is the area where the Minnaert Building and the Buys Ballot Building, amongst others, are located. To ensure that construction traffic flows more safely and efficiently through the area, a new exit is being constructed from Sorbonnelaan to Leuvenlaan.

Eliminating cancer with light

Killing tumors with light. Is that something for the distant future? Certainly not! UMC Utrecht and start-up Lumox are now going to test an innovative therapy in a first patient study.

Opening Utrecht Science Week with keynote by Juliette Legler on the hidden influence of environmental chemicals

On Friday, September 25, the annual science festival ‘Utrecht Science Week’ kicks off once again at Utrecht Science Park. We are pleased to announce that this year, Prof. Dr. Ir. Juliette Legler will deliver the Utrecht Science Lecture. Juliette Legler is Professor of Toxicology at the Faculty of Veterinary Medicine at Utrecht University and leads the ‘One Health Toxicology’ group at the Institute for Risk Assessment Sciences (IRAS).